• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Evolent Health

Ex-Medtronic strategy veep Oesterle joins VC shop New Enterprise Associates | Personnel Moves

September 10, 2015 By Fink Densford

Venture capital firm New Enterprise Associates said today it picked up ex-Medtronic (NYSE:MDT) executive veep Dr. Stephen Oesterle as a venture partner for the firm. Prior to being an executive veep for the medical giant, Oesterle served as senior veep of medicine and technology, and served as a member of the executive committee for 14 years, […]

Filed Under: Business/Financial News Tagged With: Allergan, Boston Scientific, Ceterix Orthopaedics, cyberonics, Evolent Health, iCad Inc., Intronix, Iridex Corp., Johnson and Johnson, LeMaitre Vascular Inc., LivaNova, Medtronic, New Enterprise Associates, Personnel Moves, Seno Medical Instruments, Sorin Group, STAAR Surgical Co, VisionCare Ophthalmic Technologies, Zoll Medical

Medtech trio sets $297m offering terms

May 26, 2015 By Brad Perriello Leave a Comment

IPO Tuesday: Medtech trio sets offering terms

A trio of medtech companies set terms for their upcoming public offerings today, announcing plans to raise a collective $297 million.

Filed Under: Funding Roundup, Initial Public Offering (IPO), News Well Tagged With: Corindus Vascular Robotics, EndoChoice, Evolent Health

Value-based healthcare goes public: Evolent plans $100m IPO

May 5, 2015 By Brad Perriello Leave a Comment

Value-based healthcare goes public: Evolent plans $100m IPO

Evolent Health today registered for a $100 million initial public offering for its value-based healthcare software platform as it looks to capitalize on its estimated $10 billion market.

Arlington, Va.-based Evolent, founded in 2011, said it plans to list on the New York Stock Exchange under the "EVH" symbol.

Filed Under: Initial Public Offering (IPO), News Well, Software / IT Tagged With: Evolent Health, value-based healthcare

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2

Primary Sidebar

DeviceTalks Weekly

June 24, 2022
How innovative design, commercial strategy is building Cala Trio’s bioelectronic medicine market
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS